SEC Form 4
Staar Surgical Co (STAA) insider trading
In the 12 months to Nov 15, 2026, one STAA insider reported open-market purchases of $62.8M across 4 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $62.8M
- 4 filings · Neal C. Bradsher, Director
$ excludes 11 trades without a price.
Who traded STAA, and when
- Purchase
STAA daily close from Nov 17, 2025 to Nov 13, 2026, between $16.10 and $33.34, last $26.39. 0 sale and 4 purchase filings by 1 insider, marked at their filing dates. Neal C. Bradsher, 10% owner → Director: bought $62.8M across 4 filings, first filed Nov 21, 2025, last Mar 13, 2026.
Largest mark · tap a row for others
Neal C. Bradsher · 10% owner
Purchase $41,060,317
1,500,000 shares at $27.37 avg
Filed Nov 21, 2025 · traded Nov 19
Close on filing date $28.00
Neal C. Bradsher · 10% owner → Director
10% owner → Director
$62.8M boughtOpen-market trades
4 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Neal C. Bradsher | 10% owner → Director | — | $62.8M | 4 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Neal C. Bradsher Director | Purchase | 670,213 | $18.30 | $12.3M | Multiple accounts | |
traded | Neal C. Bradsher 10% owner | Purchase | 27,485 | $22.05 | $606.1K | Multiple accounts | |
traded | Neal C. Bradsher 10% owner | Purchase | 406,653 | $21.68 | $8.8M | Multiple accounts | |
traded | Neal C. Bradsher 10% owner | Purchase | 1,500,000 | $27.37 | $41.1M | Multiple accounts |
GET /stocks/filings/vX/form-4?tickers=STAA&filing_date.gte=2025-11-15&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"STAA"
],
"issuer_cik": "0000718937",
"owner_cik": "0001278387",
"accession_number": "0000919574-26-001617",
"form_type": "4",
"filing_date": "2026-03-13",
"period_of_report": "2026-03-11",
"issuer_name": "STAAR SURGICAL CO",
"issuer_trading_symbol": "STAA",
"owner_name": "BROADWOOD CAPITAL INC",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-13",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 316017,
"transaction_price_per_share": 18.615,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 16123842,
"transaction_value": 5882656.454999999,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F4",
"description": "This constitutes the weighted average purchase price. The prices range from $18.10 to $18.84. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."
},
{
"id": "F1",
"description": "The reported securities are directly owned by Broadwood Partners, L.P. (\"Broadwood Partners\") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. (\"Broadwood Capital\") as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."
}
]
},
{
"tickers": [
"STAA"
],
"issuer_cik": "0000718937",
"owner_cik": "0001278387",
"accession_number": "0000919574-26-001617",
"form_type": "4",
"filing_date": "2026-03-13",
"period_of_report": "2026-03-11",
"issuer_name": "STAAR SURGICAL CO",
"issuer_trading_symbol": "STAA",
"owner_name": "BROADWOOD CAPITAL INC",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-12",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 299432,
"transaction_price_per_share": 18.1154,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 15807825,
"transaction_value": 5424330.4528,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F3",
"description": "This constitutes the weighted average purchase price. The prices range from $17.43 to $18.39. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."
},
{
"id": "F1",
"description": "The reported securities are directly owned by Broadwood Partners, L.P. (\"Broadwood Partners\") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. (\"Broadwood Capital\") as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 52 records
- Option exercises18 records
- Tax withholding23 records
- Grants and awards11 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Staar Surgical Co's CEO sold stock?
No. Warren Foust and Deborah J. Andrews (CEOs) made no open-market sales filed as CEO in the last 12 months.
How current is STAA’s insider data?
These are STAA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track STAA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for STAA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.